Literature DB >> 13716946

Chemotherapy of solid cancer arising from the gastro-intestinal tract.

J D HURLEY, E H ELLISON.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/therapy; GASTROINTESTINAL SYSTEM/neoplasms

Mesh：

Substances：

Year:  1960        PMID： 13716946      PMCID： PMC1613773          DOI： 10.1097/00000658-196010000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  18 in total

1.  Carcinoid of the rectum; report of case with thirteen years' survival; treated with intra-arterial nitrogen mustard.

Authors:  F W ELLIS
Journal:  Cancer       Date:  1957 Jan-Feb       Impact factor: 6.860

2.  Triethylenethiophosphoramide therapy complicated by overwhelming infection with Clostridium welchii; report of two cases.

Authors:  G E MOORE; T G WATSON
Journal:  Cancer       Date:  1957 Mar-Apr       Impact factor: 6.860

3.  The effect of triethylenethiophosphoramide on fifty patients with incurable neoplastic diseases.

Authors:  J C WRIGHT; P FOSTER; B BILLOW; S L GUMPORT; J P COBB
Journal:  Cancer       Date:  1957 Mar-Apr       Impact factor: 6.860

4.  Carcinoma of the gall bladder.

Authors:  W J BURDETTE
Journal:  Ann Surg       Date:  1957-06       Impact factor: 12.969

5.  Biological effects of the phosphoramides in patients with advanced cancer.

Authors:  E W HUMPHREY; C R HITCHCOCK
Journal:  Cancer       Date:  1957 Mar-Apr       Impact factor: 6.860

6.  Comparative therapeutic activity of the nitrogen mustards and allied compounds.

Authors:  M P SYKES; F S PHILLIPS; D A KARNOFSKY
Journal:  Med Clin North Am       Date:  1956-05       Impact factor: 5.456

7.  Cancer statistics: incidence, mortality, and results of treatment.

Authors:  C S CAMERON
Journal:  Med Clin North Am       Date:  1956-05       Impact factor: 5.456

8.  Results of treatment of carcinoma of pancreas.

Authors:  E S STAFFORD; I R TRIMBLE; J N CLASSEN
Journal:  Ann Surg       Date:  1954-06       Impact factor: 12.969

9.  Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-1-norleucine (DON) in human neoplastic disease.

Authors:  G B MAGILL; W P MYERS; H C REILLY; R C PUTNAM; J W MAGILL; M P SYKES; G C ESCHER; D A KARNOFSKY; J H BURCHENAL
Journal:  Cancer       Date:  1957 Nov-Dec       Impact factor: 6.860

10.  Triethylenethiophosphoramide (thio-tepa) in the treatment of neoplastic disease.

Authors:  J E ULTMANN; G A HYMAN; C CRANDALL; H NAUJOKS; A GELLHORN
Journal:  Cancer       Date:  1957 Sep-Oct       Impact factor: 6.860
View more
  3 in total

Review 1.  Chemotherapy in colorectal cancer.

Authors:  T J McElwain
Journal:  Proc R Soc Med       Date:  1973-12

2.  A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.

Authors:  Robert P Whitehead; Jacqueline K Benedetti; James L Abbruzzese; Bach Ardalan; J Wendall Goodwin; Stanley P Balcerzak; Wolfram E Samlowski; Heinz-Josef Lenz; John S Macdonald
Journal:  Invest New Drugs       Date:  2004-08       Impact factor: 3.850

3.  A REPORT OF THE SYSTEMIC USE OF 5-FLUOROURACIL IN THE TREATMENT OF CHINESE CANCER PATIENTS.

Authors:  D P CHAN; J H HO; A W WOO
Journal:  Br J Cancer       Date:  1964-03       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.